| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85684b98f144e5572933e241819f7b25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1ae352d2efc496096fe3c7bc69b3bf6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-191
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate |
2013-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe175b142917f6d23e3ae7184d31c155 |
| publicationDate |
2013-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013344025-A1 |
| titleOfInvention |
Method for the administration of ligands, agonists of ligands of the tnf family with reduced toxicity |
| abstract |
The present invention concerns the use of a multimerized form of ligands of the TNF family for the preparation of a medicament for injection into an appropriate cavity of the body, for the treatment of diseases wherein cell proliferation has to be controlled wherein the ligand of the TNF family is selected among Fas ligand, CD40L, TRAIL and APRIL. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10626145-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10738081-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11186611-B2 |
| priorityDate |
2003-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |